Evidence map›Paper›PMID 28817613›Full record

ArticlePloS one2017

Diflunisal inhibits prestin by chloride-dependent mechanism.

Guillaume Duret, Fred A Pereira, Robert M Raphael

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Guillaume DuretRice University, Department of Electrical and Computer Engineering, Houston, Texas.ORCID http://orcid.org/0000-0003-1910-9025
Fred A PereiraHuffington Center on Aging, Department of Otolaryngology-Head and Neck Surgery and Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Robert M RaphaelRice University, Department of Bioengineering, Houston, Texas.

Funding

Biophysical Basis of Organization and Dynamics of Prestin Membrane ComplexesR01DC009622 · NIDCD · RICE UNIVERSITY · PI RAPHAEL, ROBERT M · 2009 to 2013
$1.8M
NIDCD NIH HHS R01 DC009622
6 · The paper itself

Abstract

The motor protein prestin is a member of the SLC26 family of anion antiporters and is essential to the electromotility of cochlear outer hair cells and for hearing. The only direct inhibitor of electromotility and the associated charge transfer is salicylate, possibly through direct interaction with an anion-binding site on prestin. In a screen to identify other inhibitors of prestin activity, we explored the effect of the non-steroid anti-inflammatory drug diflunisal, which is a derivative of salicylate. We recorded prestin activity by whole-cell patch clamping HEK cells transiently expressing prestin and mouse outer hair cells. We monitored the impact of diflunisal on the prestin-dependent non-linear capacitance and electromotility. We found that diflunisal triggers two prestin-associated effects: a chloride independent increase in the surface area and the specific capacitance of the membrane, and a chloride dependent inhibition of the charge transfer and the electromotility in outer hair cells. We conclude that diflunisal affects the cell membrane organization and inhibits prestin-associated charge transfer and electromotility at physiological chloride concentrations. The inhibitory effects on hair cell function are noteworthy given the proposed use of diflunisal to treat neurodegenerative diseases.

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalCell MembraneCells, CulturedChloridesDiflunisalHair Cells, Auditory, OuterHEK293 CellsHumansMembrane PotentialsMiceMice, Inbred C57BLMolecular Motor ProteinsAnti-Inflammatory Agents, Non-SteroidalChloridesDiflunisalMolecular Motor ProteinsPres protein, mouse

Identifiers

PMID28817613
PMCPMC5560734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.